Characteristics | Low GCI N = 208a | Medium GCI N = 207a | High GCI N = 207a | Missing(%) | P-value2 |
---|---|---|---|---|---|
Range |  ≤ 88.82 | 88.82–108.79 |  > 108.79 |  |  |
Demographics | |||||
 Male | 133 (64%) | 137 (66%) | 132 (64%) | 0 | 0.8 |
 Age (years) | 67.97 (61.00, 76.08) | 70.56 (61.63, 78.69) | 73.99 (66.27, 80.00) | 0 |  < 0.001 |
Race | Â | Â | Â | 0 | 0.2 |
 Asian | 6 (2.9%) | 2 (1.0%) | 4 (1.9%) |  |  |
 Black/African American | 14 (6.7%) | 12 (5.8%) | 16 (7.7%) |  |  |
 Hispanic or Latino | 13 (6.3%) | 6 (2.9%) | 7 (3.4%) |  |  |
 White | 122 (59%) | 147 (71%) | 124 (60%) |  |  |
 Other | 53 (25%) | 40 (19%) | 56 (27%) |  |  |
Prognosis | |||||
 Length of ICU stay (days) | 3.77 (2.73, 5.65) | 3.46 (2.45, 5.19) | 4.05 (2.81, 6.94) | 0 | 0.071 |
 Length of hospital stay (days) | 10.85 (7.98, 15.68) | 10.21 (7.14, 14.57) | 11.05 (6.29, 16.01) | 0 | 0.6 |
 Hospital mortality | 12 (5.8%) | 15 (7.2%) | 36 (17%) | 0 |  < 0.001 |
 one-year mortality | 38 (18%) | 40 (19%) | 76 (37%) | 0 |  < 0.001 |
 Hypoglycemia | 91 (44%) | 60 (29%) | 32 (15%) | 0 |  < 0.001 |
Interventions | |||||
 PCI | 21 (10%) | 25 (12%) | 44 (21%) | 0 | 0.003 |
 CABG | 148 (71%) | 122 (59%) | 68 (33%) | 0 |  < 0.001 |
 Dialysis within the first 24 h of ICU admission | 2 (1.0%) | 8 (3.9%) | 16 (7.7%) | 0 | 0.003 |
 Mechanical ventilation within the first 24 h of ICU admission | 127 (61%) | 100 (48%) | 96 (46%) | 0 | 0.005 |
 Usage of vasoactive drugs within the first 24 h of ICU admission | 124 (60%) | 115 (56%) | 103 (50%) | 0 | 0.13 |
GCI-related | |||||
 Mean blood glucose in ICU stay (mmol/L) | 8.01 (7.29, 9.35) | 8.37 (7.51, 9.41) | 10.13 (8.56, 12.06) | 0 |  < 0.001 |
 Median blood glucose in ICU stay (mmol/L) | 7.61 (6.78, 8.76) | 8.00 (7.11, 9.06) | 9.53 (8.16, 11.32) | 0 |  < 0.001 |
 HbA1c (%) | 8.70 (7.60, 10.50) | 6.90 (6.35, 7.70) | 6.40 (5.85, 7.20) | 0 |  < 0.001 |
 GCI | 76.27 (64.04, 82.77) | 99.87 (94.28, 104.68) | 125.62 (116.07, 143.08) | 0 |  < 0.001 |
Comorbidities | |||||
 Congestive heart failure | 113 (54%) | 113 (55%) | 151 (73%) | 0 |  < 0.001 |
 Cerebrovascular disease | 50 (24%) | 41 (20%) | 49 (24%) | 0 | 0.5 |
 Chronic pulmonary disease | 44 (21%) | 52 (25%) | 57 (28%) | 0 | 0.3 |
 Renal disease | 65 (31%) | 82 (40%) | 95 (46%) | 0 | 0.009 |
 Cancer | 10 (4.8%) | 13 (6.3%) | 12 (5.8%) | 0 | 0.8 |
Illness severity | |||||
 APSIII | 41.50 (34.00, 53.00) | 42.00 (34.00, 55.00) | 49.00 (38.00, 62.00) | 0 |  < 0.001 |
 Urine output within the first 24 h of ICU admission (mL) | 1,525.00 (1,077.25, 1,986.25) | 1,575.00 (992.50, 2,323.75) | 1,310.00 (782.50, 2,110.00) | 11(1.77) | 0.13 |
Laboratory results | |||||
 PT (s) | 14.15 (13.05, 15.55) | 14.13 (13.01, 15.30) | 13.65 (12.50, 15.25) | 16 (2.27) | 0.085 |
 APTT (s) | 36.13 (29.19, 49.90) | 38.70 (30.28, 62.18) | 40.23 (29.91, 62.34) | 15 (2.41) | 0.049 |
 RDW (%) | 14.00 (13.20, 14.95) | 14.15 (13.33, 15.23) | 14.40 (13.50, 15.70) | 1 (0.16) | 0.021 |
 Hematocrit (%) | 30.63 (27.94, 34.50) | 30.70 (27.98, 36.13) | 30.70 (27.80, 36.03) | 0 |  > 0.9 |
 Hemoglobin (g/dL) | 10.23 (9.35, 11.45) | 10.05 (9.25, 11.80) | 10.15 (9.00, 11.93) | 0 | 0.8 |
 Platelets (× 109/L) | 184.50 (144.38, 236.38) | 190.00 (145.50, 265.25) | 203.00 (157.50, 274.75) | 0 | 0.050 |
 WBC (× 109/L) | 12.75 (9.94, 15.70) | 12.25 (10.03, 15.58) | 12.65 (10.40, 15.73) | 0 | 0.6 |
 Anion Gap (mmol/L) | 13.50 (11.38, 16.00) | 14.50 (12.00, 16.50) | 15.50 (13.00, 18.50) | 0 |  < 0.001 |
 Bicarbonate (mmol/L) | 23.00 (21.50, 24.50) | 23.00 (20.75, 25.00) | 22.50 (20.00, 25.00) | 0 | 0.8 |
 BUN (mg/dL) | 19.50 (14.50, 30.13) | 24.00 (16.50, 35.25) | 28.00 (19.50, 50.75) | 0 |  < 0.001 |
 Creatinine (mmol/L) | 1.05 (0.85, 1.40) | 1.15 (0.85, 1.75) | 1.45 (1.00, 2.53) | 0 |  < 0.001 |
 Potassium (mmol/L) | 4.40 (4.10, 4.75) | 4.35 (4.03, 4.70) | 4.35 (3.95, 4.70) | 1 (0.16) | 0.5 |
 Sodium (mmol/L) | 137.50 (136.00, 140.00) | 138.00 (136.00, 139.50) | 137.50 (134.50, 140.00) | 0 | 0.7 |